Sunshine biopharma a buy
7/31/2024 11:33pm
**Sunshine Biopharma, Inc. (SBFM) does not appear to be a strong candidate for day trading today.** Here's why:
1. **Recent Insider Activity**: There have been no informative buys or sells by corporate insiders in the last 3 months. Insider Confidence Signal is currently Negative, with a sentiment expressed based on insider transactions over the past 3 months.
2. **Stock Performance**: The company has experienced significant revenues growth, with a 454% increase in FY2023. However, the company has also reported a net loss of $4.636M for the trailing twelve months. This financial performance suggests that while there has been growth, it may not be reflected in the stock price.
|Ticker|Name|RSI|MACD|KDJ|Boll|Date|code|market_code|
|---|---|---|---|---|---|---|---|---|
|SBFM.O|Sunshine Biopharma|29.9101||5.6993|0.3209|20240730|SBFM|186|
|SBFM.O|Sunshine Biopharma||0.0375|||20240731|SBFM|186|
|Ticker|Name|Trading Volume|Date|code|market_code|
|---|---|---|---|---|---|
|SBFM.O|Sunshine Biopharma|349494|20240731|SBFM|186|
3. **Technical Indicators**: The stock's technical indicators are not strongly suggestive of a buy. The MACD is at 0.04, which is close to the neutral zone but leaning towards a Sell signal. The RSI is 29.91, indicating that the stock may be oversold but also suggesting a lack of strong buying momentum. The stock is trading below its 20-Day, 50-Day, and 100-Day exponential moving averages, which could be seen as a Sell signal.
4. **Analyst Ratings and Price Targets**: There is no available consensus rating, but the average price target is not available either.
5. **Market Sentiment**: The stock has experienced a high level of trading volume, with 349,477 shares changing hands on July 31, 2024. This could indicate a high level of market interest, but it may also suggest that the stock is prone to significant price swings.
6. **Short Interest**: The short interest in SBFM is not available, which could be a factor for day traders looking for opportunities in shorted stocks.
Given these points, SBFM does not appear to be a strong buy for day trading today. The mixed technical signals, recent price volatility, lack of recent positive insider activity, and the company's financial performance suggest caution.